GoldenGolden
Aprinoia Therapeutics

Aprinoia Therapeutics

Aprinoia Therapeutics is a developer of diagnostics, therapeutics and drug discovery platform for neurological diseases.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

January 2018
Aprinoia Therapeutics raises a $11,100,000 series B round from DCI Partners, KTB Network, ShangPharma and TaiAn Technologies.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Aprinoia Therapeutics Inc funding round, January 2018
11,100,000
January 2018
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Insilico Medicine Hong Kong Limited
December 30, 2020
www.prnewswire.com:443
/PRNewswire/ -- Insilico Medicine is pleased to announce that it has entered into a research collaboration with APRINOIA Therapeutics to utilize Insilico's...
APRINOIA Therapeutics
December 16, 2020
www.prnewswire.com:443
/PRNewswire/ -- APRINOIA Therapeutics Inc. today announced that they had executed a worldwide non-exclusive licensing agreement for Biogen Inc. (Nasdaq: BIIB)...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.